Marketwatch Alembic Pharma JV gets USFDA nod for plaque psoriasis treatment drug Admin October 4, 2019 Alembic has a cumulative total of 103 ANDA approvals (91 final approvals and 12 tentative approvals) from USFDA. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email